Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Interest & Investment Income: 2023-2024

Historic Interest & Investment Income for Prime Medicine (PRME) over the last 2 years, with Dec 2024 value amounting to $3.5 million.

  • Prime Medicine's Interest & Investment Income rose 63.70% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 86.02%. This contributed to the annual value of $3.5 million for FY2024, which is 25.29% up from last year.
  • Per Prime Medicine's latest filing, its Interest & Investment Income stood at $3.5 million for FY2024, which was up 25.29% from $2.8 million recorded in FY2023.
  • In the past 5 years, Prime Medicine's Interest & Investment Income registered a high of $3.5 million during FY2024, and its lowest value of $2.8 million during FY2023.
  • Moreover, its 2-year median value for Interest & Investment Income was $3.2 million (2023), whereas its average is $3.2 million.
  • Data for Prime Medicine's Interest & Investment Income shows a peak YoY increased of 25.29% (in 2024) over the last 5 years.
  • Prime Medicine's Interest & Investment Income (Yearly) stood at $2.8 million in 2023, then rose by 25.29% to $3.5 million in 2024.